Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly…
NCT00003996 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003996 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
| Official title | A Phase II Trial of Pre-irradiation Chemotherapy With BCNU, Cisplatin and Oral Etoposide Combined With Radiation Therapy in the Treatment of Grade 4 Astrocytoma (Glioblastoma) |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Radiation |
| Interventions | carmustine, chemotherapy, cisplatin, etoposide, radiation therapy |
| Enrollment | 93 |
| Start date | May 1, 1999 |
| Primary completion | Aug 1, 2001 |
| Completion | May 1, 2008 |
| First posted | Jun 17, 2004 |
| Last update posted | Dec 7, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: